Marie-Claude Fournié-Zaluski
Profile
Marie-Claude Fournié-Zaluski is the founder of Pharmaleads SA, a company founded in 2000.
She also worked as a Professor at Université Pierre et Marie Curie.
Dr. Fournié-Zaluski holds a doctorate degree from Université Pierre et Marie Curie.
Former positions of Marie-Claude Fournié-Zaluski
| Companies | Position | End |
|---|---|---|
| Université Pierre et Marie Curie | Corporate Officer/Principal | - |
Pharmaleads SA
 Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Founder | - |
Training of Marie-Claude Fournié-Zaluski
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Pharmaleads SA
Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Health Technology |
| Université Pierre et Marie Curie | Consumer Services |
- Stock Market
- Insiders
- Marie-Claude Fournié-Zaluski
